Indian Science Technology and Engineering facilities Map
 
Supplier Map
Service Map
Preivious Next  

  Digital Catalogue for Technology and Products Development


   Technology and Product Development

    Basic Information

Technology developed: Cationic polymeric microparticles as carriers of drug for treatment of Tuberculosis infection (TP19762774223)
Category: Product(Hardware/Material/Software)
Details of Inventor(s):
Inventor Institution/Organization/Company Department Designation
Pallavi Raj Sharma Indian Institute of Science BioSystems Science and Engineering PhD. Studen
Rachit Agarwa Indian Institute of Science BioSystems Science and Engineering Assistant Professor
Technical Application Area: Healthcare
If 'Other', please specify:
Bioengineering Medical
Please give more details of new technical application area:
Organization(s):
Indian Institute of Science (IISc) Bengaluru
Affiliated Ministry: Select One...
Type of technology development: Indigenous
Does the technology help in replacing any import items currently
procured from outside India?
No
Does the technology have export potential? Yes
Category of Technology developed: Futuristic
Stage of Development: Prototype Level
Please describe in detail including the TRL Level:
We have developed a lab prototype that is being tested in vitro and in mice. TRL3

    Abstract:

Applications: The major potential application for this product is to treat intracellular lung infections such as in case of tuberculosis
Advantages: The advantage of this technology are 1 Inhalable treatments patient compliant 2 Efficient intracellular delivery 3 Sustained release of drug resulting in lower frequency of administration and better pharmacokinetics

    Technology Inputs:

Imported Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Indigenous Equipment/Spare Parts:
Equipment/Spare Parts Year ITC-HS Code
NA
Imported Raw Materials:
Raw Materials Year ITC-HS Code
Polymers such as PLGA 2017-18
Indigenous Raw Materials:
Raw Materials Year ITC-HS Code
NA
Existing R&D Facilities used:
Facilities Year ITC-HS Code
Facilities at BSSE materials and MRDG at IISc were utilized 2017-18

   Patents & Publications:

Patents:
Filed Patents (No.) Granted Patents (No.) Year
0 0 NA
Publications:
Submitted (No.) Published (No.) Year
0 0 NA

    Commercialization Potential:

Who are the Potential Licensees? Novartis, Cipla, Lupin and any other pharma company working with TB infections
What commercially available products address
the same problem?
Company Product Problem Addressed
Several companies to list Rifampicin Reduction in bacterial infection
Isoniazid
Pyrazinamide
Ethambutol
Would you like to develop this invention further with
corporate research support?
Yes
Would you be interested in participating in cluster based
programs for commercialization research or business
planning for your invention?
No
      Submitted by: Prof KVS Hari Date of Submission: 25-11-2020



Chat Room      Write Review     Talk to Experts


THE VISION
THE MISSION
ABOUT I-STEM
It has always been the basic tenet of the Government of India, in generously funding R&D efforts at academic institutions over the years, that facilities established through such support be made available to those needing them and qualified to make use of them for their own research work
read more >>

However, this was never easy or straightforward for, among other reasons, there was no ready source of information of what facility was available and where. Thanks to the Web, it is much easier today to have a national and regional “inventory of resources”, so as to match users with the resources they need, and to do all this in an efficient and transparent manner.

This can lead to a leap in R&D productivity and greatly enhance the effectiveness of public investment. This is the motivation behind I-STEM.
read less <<
Visitor Hit Counter
Hosted at Indian Institute of Science
Copyright © 2024 I-STEM. All rights reserved.
Audited by: STQC Bengaluru.